Effects of amiodarone on cardiac electrophysiology in right ventricular rapid pacing-induced heart failure dogs

被引:0
作者
Zhou, SX [1 ]
Zhang, XM [1 ]
Wu, W [1 ]
Chen, XC [1 ]
机构
[1] Sun Yat Sen Univ Med Sci, Sun Yat Sen Mem Hosp, Dept Internal Med, Div Cardiol, Guangzhou 510120, Peoples R China
来源
ACTA PHARMACOLOGICA SINICA | 1998年 / 19卷 / 04期
关键词
amiodarone; congestive heart failure; electrophysiology; action potentials; ventricular fibrillation; hemodynamics;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AIM: To study the effects of amiodarone (Ami) on cardiac electrophysiologic properties and ventricular fibrillation threshold (VFT) in right ventricular rapid pacing-induced congestive heart failure (CHF) dogs. METHODS: Dogs (n = 25) were randomly allocated into 3 groups: A) control group; B) CHF group induced by right ventricular rapid pacing (4 pulses.s(-1)) for 4 - 5 wk; C) CHF models po Ami 300 mg.d(-1) for 4 - 5 wk. The electrophysiologic parameters and VET were evaluated by electric stimulation and monophasic action potential (MAP) recording. RESULTS: In CHF models, ventricular MAP duration (MAPD(90)), ventricular late repolarization duration (VLRD), and intraventricular conduction time (IVCT) were prolonged by 43 %, 318 %, and 19 %, respectively; the ratio of ventricular effective refractory period (VERP) to MAPD(90) (VERP/MAPD(90)) and VFT were decreased by 13 % and 48 % respectively; the dispersion of ventricular recovery time (RT-D) was increased by 185 %. In CHF models, Ami had no effects on ventricular MAPD(90), but increased VERP/MAPD(90), IVCT, and VFT by 15 %, 10 %, and 67 %, respectively, shortened VLRD by 87 %; and decreased RT-D by 87 %. Ami had no significant influences on the hemodynamic parameters of the CHF dogs. CONCLUSION: Ami normalizes the cardiac electrophysiologic properties in CHF dogs.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 11 条
[1]   RAPID VENTRICULAR PACING IN THE DOG - PATHOPHYSIOLOGIC STUDIES OF HEART-FAILURE [J].
ARMSTRONG, PW ;
STOPPS, TP ;
FORD, SE ;
DEBOLD, AJ .
CIRCULATION, 1986, 74 (05) :1075-1084
[2]   RANDOMIZED TRIAL OF LOW-DOSE AMIODARONE IN SEVERE CONGESTIVE-HEART-FAILURE [J].
DOVAL, HC ;
NUL, DR ;
GRANCELLI, HO ;
PERRONE, SV ;
BORTMAN, GR ;
CURIEL, R .
LANCET, 1994, 344 (8921) :493-498
[3]   ROLE OF ELECTROPHYSIOLOGIC TESTING IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH KNOWN AND SUSPECTED BRADYCARDIAS AND TACHYCARDIAS [J].
FISHER, JD .
PROGRESS IN CARDIOVASCULAR DISEASES, 1981, 24 (01) :25-90
[4]   METHOD AND THEORY OF MONOPHASIC ACTION-POTENTIAL RECORDING [J].
FRANZ, MR .
PROGRESS IN CARDIOVASCULAR DISEASES, 1991, 33 (06) :347-368
[5]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHY OF AMIODARONE IN BIOLOGICAL-FLUIDS [J].
LESKO, LJ ;
MARION, A ;
CANADA, AT ;
HAFFAJEE, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (12) :1366-1368
[6]   ELECTROPHYSIOLOGIC SUBSTRATE ASSOCIATED WITH PACING-INDUCED HEART-FAILURE IN DOGS - POTENTIAL VALUE OF PROGRAMMED STIMULATION IN PREDICTING SUDDEN-DEATH [J].
LI, HG ;
JONES, DL ;
YEE, R ;
KLEIN, GJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (02) :444-449
[7]  
LU F, 1992, ACTA PHARM SINIC, V13, P364
[8]   FREQUENCY-DEPENDENT ELECTROPHYSIOLOGIC EFFECTS OF AMIODARONE IN HUMANS [J].
SAGER, PT ;
UPPAL, P ;
FOLLMER, C ;
ANTIMISIARIS, M ;
PRUITT, C ;
SINGH, BN .
CIRCULATION, 1993, 88 (03) :1063-1071
[9]   AMIODARONE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND ASYMPTOMATIC VENTRICULAR ARRHYTHMIA [J].
SINGH, SN ;
FLETCHER, RD ;
FISHER, SG ;
SINGH, BN ;
LEWIS, HD ;
DEEDWANIA, PC ;
MASSIE, BM ;
COLLING, C ;
LAZZERI, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (02) :77-82
[10]   HEMODYNAMIC AND NEUROHUMORAL RESPONSE IN HEART-FAILURE PRODUCED BY RAPID VENTRICULAR PACING [J].
TRAVILL, CM ;
WILLIAMS, TDM ;
PATE, P ;
SONG, G ;
CHALMERS, J ;
LIGHTMAN, SL ;
SUTTON, R ;
NOBLE, MIM .
CARDIOVASCULAR RESEARCH, 1992, 26 (08) :783-790